Symbol
NAMS on Nasdaq
Investment type
Equity / Common Stock
Latest Disclosed Ownership
11.4M shares
Security Ownership
9.99%

BCLS Fund III Investments, LP ownership in NewAmsterdam Pharma Co N.V. Common Stock (NAMS)

2025-11-07 - BCLS Fund III Investments, LP has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 11.4M shares of NewAmsterdam Pharma Co N.V. Common Stock (NAMS). This represents 9.99% percent ownership of the company.